Chronic Pain Clinical Trial
Official title:
Activating Motor System to Relieve Pain in Elderly: What is the Role of Physical Exercise and Transcranial Stimulation
Physical exercises are known to reduce chronic pain in elderly individuals by activating the motor system. However, it seems that exercises are not effective for everyone. The investigators believe that elderly individuals with altered corticospinal tract will be those in whom the exercise alone are not sufficient to relieve pain. For those patients, adding an exogenous stimulation of the motor system such as transcranial direct current stimulation (tDCS) would facilitate the corticospinal tract, and consequently, would help exercises to relieve chronic pain. The investigators hypothesize that combining tDCS with the exercises will be more effective than exercises alone, but only in individuals who initially show low corticospinal projections.
| Status | Recruiting |
| Enrollment | 32 |
| Est. completion date | December 2024 |
| Est. primary completion date | October 1, 2023 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 60 Years and older |
| Eligibility | Inclusion Criteria: - To have musculoskeletal chronic pain - Not to change medication and life habits during the study Exclusion Criteria: - People physically active before the study (more then 150 min of moderate to vigorous exercise par week) - To have an uncontrolled cardiovascular disease - To have orthopedic limitation or contraindication to physical exercise - To have contraindication to tDCS - To have contraindication to TMS - To have contraindication to MRI |
| Country | Name | City | State |
|---|---|---|---|
| Canada | Grace Village | Sherbrooke | Quebec |
| Canada | Research Centre on Aging | Sherbrooke | Quebec |
| Lead Sponsor | Collaborator |
|---|---|
| Université de Sherbrooke |
Canada,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes in Pain intensity | Pain intensity will be assessed with a pain logbook containing a numerical rating scale from 0 to 10 | Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6) | |
| Secondary | Corticospinal excitability (TMS) | Corticospinal tract excitability will be assessed with transcranial magnetic stimulation (TMS) | Before intervention, Follow-up 1 week after, Follow-up 1 month after | |
| Secondary | Corticospinal excitability (dMRI) | Corticospinal tract excitability will be assessed diffusion magnetic resonance imaging | Before intervention, Follow-up 1 week after, Follow-up 1 month after | |
| Secondary | Functional connectivity | Functional connectivity will be assessed with functional magnetic resonance imaging | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | McGill pain questionnaire | McGill pain questionnaire will be used to assess pain in its globality. Score from 0 to 72, higher score means worse outcome. | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | Brief pain inventory | Brief pain inventory will be used to assess pain in its globality. Score from 0 to 70, higher score means worse outcome | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | Beck depression inventory | Beck depression inventory will be used to assess pain in its globality. Score from 0 to 39, higher score means worse outcome | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | Beck anxiety inventory | Beck anxiety inventory will be used to assess pain in its globality. Score from 0 to 63, higher score means worse outcome | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | Margolis pain drawing and scoring system | Margolis pain drawing and scoring system will be used to assess pain in its globality. Score from 0 to 45, higher score means worse outcome | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | Patient global impression of change questionnaire | patient global impression of change questionnaire will be used to assess pain in its globality. Score from 0 to 18 and a percentage from 0 to 100. Higher scores mean better outcome | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | Tampa questionnaire | Tampa questionnaire will be used to assess pain in its globality. Score from 0 to 68, higher score means worse outcome | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention | |
| Secondary | Pain catastrophizing scale | Pain catastrophizing scale will be used to assess pain in its globality. Score from 0 to 52, higher score means worse outcome | Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|